Please use this identifier to cite or link to this item:
|Title:||Adipose tissue cells, lipotransfer and cancer: A challenge for scientists, oncologists and surgeons|
Jean Yves Petit
Mikhail G. Kolonin
Istituto Europeo di Oncologia
University of Texas Health Science Center at Houston
|Keywords:||Biochemistry, Genetics and Molecular Biology;Medicine|
|Citation:||Biochimica et Biophysica Acta - Reviews on Cancer. Vol.1826, No.1 (2012), 209-214|
|Abstract:||Despite recent evidence of the cancer-promoting role of adipose tissue-derived progenitor and differentiated cells, the use of lipotransfer for tissue/organ reconstruction after surgical removal of cancer is increasing worldwide. Here we discuss in a multidisciplinary fashion the preclinical data connecting obesity, adipose cells and cancer progression, as well as the clinical data concerning safety of lipotransfer procedures in cancer patients. A roadmap towards a more rationale use of lipotransfer in oncology is urgently needed and should include preclinical studies to dissect the roles of different adipose tissue-derived cells, the evaluation of drugs currently candidate to inhibit the interaction between adipose and tumor cells, and carefully designed clinical trials to investigate the safety of lipotransfer procedures in cancer patients. © 2012 Elsevier B.V.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.